Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
We are at the forefront of precision medicine, alleviating the strain on healthcare systems through our innovative automated analysis, diagnosis, and treatment solutions that cater to healthcare providers and patients globally. Congenica emerged from groundbreaking research conducted at the Wellcome Sanger Institute and the UK's National Health Service. Our offerings integrate cutting-edge technology, top-tier automation, and artificial intelligence, allowing our distinct platform to be utilized across various human diseases where genomic information plays a crucial role in revealing actionable insights. As a digital health company, we specialize in software and solutions designed for the large-scale analysis and interpretation of genomic data. Our fully automated system, enhanced with robust APIs and machine learning capabilities, aims to lighten the load on specialist staff, improve case processing efficiency, speed up decision-making, and simplify reporting. Our platform is certified, accurate, and secure, empowering clinical decisions with the utmost confidence in the resulting clinical outcomes, and we continuously strive to innovate and expand our capabilities to meet the evolving needs of the healthcare landscape.
Description
Evo 2 represents a cutting-edge genomic foundation model that excels in making predictions and designing tasks related to DNA, RNA, and proteins. It employs an advanced deep learning architecture that allows for the modeling of biological sequences with single-nucleotide accuracy, achieving impressive scaling of both compute and memory resources as the context length increases. With a robust training of 40 billion parameters and a context length of 1 megabase, Evo 2 has analyzed over 9 trillion nucleotides sourced from a variety of eukaryotic and prokaryotic genomes. This extensive dataset facilitates Evo 2's ability to conduct zero-shot function predictions across various biological types, including DNA, RNA, and proteins, while also being capable of generating innovative sequences that maintain a plausible genomic structure. The model's versatility has been showcased through its effectiveness in designing operational CRISPR systems and in the identification of mutations that could lead to diseases in human genes. Furthermore, Evo 2 is available to the public on Arc's GitHub repository, and it is also incorporated into the NVIDIA BioNeMo framework, enhancing its accessibility for researchers and developers alike. Its integration into existing platforms signifies a major step forward for genomic modeling and analysis.
API Access
Has API
Yes
API Access
Has API
No
Integrations
Evo Designer
No
GitHub
No
Hugging Face
No
NVIDIA BioNeMo
No
Integrations
Evo Designer
Yes
GitHub
Yes
Hugging Face
Yes
NVIDIA BioNeMo
Yes
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
No
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
Yes
Vendor Details
Company Name
Congenica
Founded
2014
Country
United Kingdom
Website
www.congenica.com
Vendor Details
Company Name
Arc Institute
Country
United States
Website
arcinstitute.org/tools/evo